Ashton Thomas Private Wealth’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Ashton Thomas Private Wealth's TXG Position: Q3 2026 in Review
Ashton Thomas Private Wealth reduced its 10x Genomics (TXG) stake by 14% in Q3 2026, selling an estimated $137K and leaving 14,875 shares worth $1.34M. The position accounts for 0.03% of the portfolio, ranked #486.
Ashton Thomas Private Wealth first reported a position in TXG in Q2 2024 and has held it in 6 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Ashton Thomas Private Wealth held 14,875 shares of 10x Genomics worth $1.34M as of Q3 2026.
- Ashton Thomas Private Wealth sold 2,345 10x Genomics shares in Q3 2026, an estimated $137K.
- 10x Genomics made up 0.03% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #486 holding.
- Ashton Thomas Private Wealth first reported a position in 10x Genomics in Q2 2024 and has held it in 6 quarters since.
- 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.